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INTRODUCTION {#ped412037-sec-0006}
============

Viral encephalitis (VE) and meningitis (VM) are severe infectious diseases responsible for substantial morbidity and mortality in children.[1](#ped412037-bib-0001){ref-type="ref"}, [2](#ped412037-bib-0002){ref-type="ref"} More than 100 viruses are known to cause VE and VM. The main pathogens responsible for VE and VM vary by geographical region, season, and detection methodology. In England and Wales, the most common causative agents of VE and VM were enteroviruses (EVs), herpes simplex virus (HSV) and varicella zoster virus (VZV).[3](#ped412037-bib-0003){ref-type="ref"} In America, Leber et al. reported that the most common causative agents of VE and VM were EVs and human herpesvirus 6 (HHV6).[2](#ped412037-bib-0002){ref-type="ref"} In Australia, the most common causative agents were HSV and VZV,[4](#ped412037-bib-0004){ref-type="ref"} while Japanese encephalitis virus (JEV) was the most common causative agent of VE among children in southern Vietnam.[5](#ped412037-bib-0005){ref-type="ref"}

There is no national monitoring system for infectious encephalitis or meningitis in China, and the epidemiology of pediatric VE and VM in Hebei province is poorly understood. In previous work, we reported an outbreak of encephalitis and meningitis caused by the enterovirus, echovirus 18 (E18), in Hebei province in 2015.[6](#ped412037-bib-0006){ref-type="ref"} In the present study, we explored the etiology and epidemiology of pediatric VE and VM between November 2013 and December 2015 in Hebei province.

METHODS {#ped412037-sec-0007}
=======

Patients {#ped412037-sec-0008}
--------

Pediatric patients (ages 1 month--16 years) hospitalized with acute VE and VM between Nov 2013 and Dec 2015 were enrolled in this study. Patients with demyelinating, metabolic, toxic or neurological degenerative diseases or HIV infection were excluded. The Children\'s Hospital of Hebei Province is the largest comprehensive center for pediatric health care in the province. The hospital serves more than 1,000,000 outpatients and 40,000 inpatients each year.

Clinical definition {#ped412037-sec-0009}
-------------------

Diagnosis of acute VE was based on the following criteria: (i) acute symptom onset; (ii) alteration in mental state; (iii) documented fever ≥38°C within 72 h (before or after) of clinical manifestations; (iv) generalized or partial seizures not fully explained by a preexisting seizure disorder; (v) brain parenchymal lesions on neuroimaging or abnormal electroencephalogram; (vi) no evidence of bacterial infection on microscopic examination or cerebrospinal fluid (CSF) culture.

Diagnosis of acute VM was based on the following criteria: (1) acute symptom onset; (2) fever plus symptoms such as headache, vomiting, and nuchal rigidity; (3) absence of parenchymal involvement; (4) no evidence of bacterial meningitis on microscopic examination or CSF culture.

Clinical specimens and data collection {#ped412037-sec-0010}
--------------------------------------

CSF was aseptically collected during the acute phase of infection based on clinical examination during hospitalization. All specimens were transported to the laboratory of virology at the Beijing children\'s hospital and stored at −80°C until further processing.

Data on demographic characteristics, clinical symptoms and signs, laboratory findings, neuroimaging and electroencephalography results, and patient outcomes were collected for all subjects.

PCR detection of viruses {#ped412037-sec-0011}
------------------------

Viral nucleic acid was extracted from CSF samples (0.2 mL) using the QIAamp MinElute Virus Spin Kit (QIAGEN, Germany, Cat. No. 57704), according to the manufacturer\'s instructions.

Screening for EVs, mumps virus (MuV) and JEV was performed using real‐time PCR (PCR‐fluorescent probe) (BioPerfectus Technologies, China, Cat. Nos. JC20101, JC60104, and JC70108, respectively).

Six herpes viruses, including HSV1, HSV2, VZ V, Epstein‐Barr virus (EBV), HHV6 and cytomegalovirus (CMV) were screened using a multiplex PCR method, the Seeplex^®^ meningitis‐V1 ACE Detection kit (Seegene, Korea, Cat. N. MG6611Y, V2.0).

Sequencing of the VP1 gene for EV typing {#ped412037-sec-0012}
----------------------------------------

The genotypes of EVs were determined by sequencing of partial VP1 genes and BLAST analysis. All EV‐positive samples were PCR‐amplified with primer pairs 292--222.[7](#ped412037-bib-0007){ref-type="ref"} Samples that failed to amplify using primer pairs 292--222 were subjected to amplification with primer pairs 040--011 and 012--011.[8](#ped412037-bib-0008){ref-type="ref"}

Ethics approval {#ped412037-sec-0013}
---------------

The study protocol was approved by the Medical Ethics Committee of Beijing Children\'s Hospital, Capital Medical University. Written informed consent was obtained from legal guardians of all patients prior to the collection of CSF samples.

RESULTS {#ped412037-sec-0014}
=======

Case characteristics {#ped412037-sec-0015}
--------------------

A total of 442 patients (302 boys and 140 girls) qualified for inclusion in this study after excluding patients with bacterial meningitis (n=30), autoimmune encephalitis (n=8) and mitochondrial encephalomyopathy (n=2). Of these 442 patients, 309 were diagnosed with VE (age, mean ± SD: 5.38 ± 2.60 years; age range: 1 month -- 11.2 years), while 133 were diagnosed with VM (age, mean ± SD: 6.38 ± 2.82 years; age range: 9 months -- 13.9 years). The vast majority of patients were between 3 and 10 years old \[78.96% (244/309) and 82.71% (110/133) of patients with acute VE and VM, respectively\]. The proportions of patients with VE and VM who were younger than 3 years of age were 17.80% (55/309) and 7.52% (10/133), respectively. The demographic characteristics of patients are summarized in Table [1](#ped412037-tbl-0001){ref-type="table"}.

###### 

Demographic characteristics of pediatric VE and VM patients

  Diseases               Sex   Age (years)                                  
  ---------------------- ----- ------------- -------- ---- ---- ----- ----- ----
  Encephalitis (N=309)   216   93            2.32:1   15   40   146   98    10
  Meningitis (N=133)     87    46            1.89:1   1    9    57    53    13
  Total                  303   139           2.18:1   16   49   203   151   23

John Wiley & Sons, Ltd

The most common clinical manifestations in patients with VE were headache (82.2%, 254/309), fever (75.0%, 232/309), vomiting (51.5%, 159/309), nausea (45.3%, 140/309) and lethargy (42.1%, 130/309). Other common clinical manifestations included abdominal pain (6.5%, 20/309), convulsion (6.1%, 19/309), and loss of consciousness (4.2%, 13/309). The most common clinical manifestations in patients with VM were headache (96.2%, 128/133), fever (75.2%, 100/133), vomiting (60.7%, 88/133) and nausea (37.6%, 50/133). VE and VM both occurred year‐round with a peak of cases observed during the month of July (Figure [1](#ped412037-fig-0001){ref-type="fig"}A).

![Monthly burden of viral encephalitis and meningitis cases during 2013--2015 in Hebei province, China (A). Monthly distribution of viral encephalitis (B) and viral meningitis (C) cases with confirmed etiology.](PED4-2-98-g001){#ped412037-fig-0001}

Spectrum of viral pathogens in patients with VE and VM {#ped412037-sec-0016}
------------------------------------------------------

In total, 176 VE cases we repositive for viral pathogens for an overall virus‐positive rate of 57.0% (176/309). The most commonly detected pathogens in patients with VE were EVs (55.7%, 9 8/ 17 6), HSV1 (19.9%, 35/176), EBV (6.8%, 12/176), and VZV (6.8%, 12/176). Viral pathogens were detected in 82 patients with VM for an overall virus‐positive rate of 61.7% (82/133). The most commonly detected pathogens in patients with VM were EVs (64.6%, 53/82), VZV (11.0%, 9/82), HSV1 (9.8%, 8/82), and HSV2 (7.3%, 6/82) (Figure [2](#ped412037-fig-0002){ref-type="fig"}). Neither JEV nor MuV was detected in any patient in this study.

![Distribution of viral pathogens responsible for pediatric VE and VM. EVs, human enteroviruses; HSV1, herpes simplex virus 1; HSV2, herpes simplex virus 2; VZV, varicella zoster virus; EBV, Epstein‐Barr virus; CMV, cytomegalovirus; HHV6, human herpes virus 6.](PED4-2-98-g002){#ped412037-fig-0002}

Cases of VE and VM occurred throughout the year. Cases of EV‐related VE and VM occurred from April to September. The incidence of HSV1‐associated VE was highest during July and August. No obvious seasonal trend was observed with respect to other viruses (Figure [1](#ped412037-fig-0001){ref-type="fig"}B, C).

Serotypes of enteroviruses in VE and VM {#ped412037-sec-0017}
---------------------------------------

EV genotyping was conducted by sequencing partial VP1 genes and performing BLAST analyses. EVs derived from 81 VE and 43 VM patients were typed. The EV serotypes of 17 VE samples and 10 VM samples could not be confirmed because of poor quality sequencing data. Seven EV serotypes were determined from patients with VE; these included E6 (15.3%, 15/98), E14 (1.0%, 1/98), E18 (39.8%, 39/98), E30 (15.3%, 15/98), E33 (5.1%, 5/98), Coxsackievirus B5 (CV‐B5) (5.1%, 5/98), and CV‐A9 (1.0%, 1/98). Five EV serotypes were determined from patients with VM; these included E6 (7.5%, 4/53), E18 (43.4%, 23/53), E30 (20.8%, 11/53), E33 (3.8%, 2/53), and CV‐B5 (5.7%, 3/53). All of the typed EVs belonged to the EV‐B group; the most common EVs were E18 (41.1%, 62/151), E30 (17.2%, 26/151) and E6 (12.6%, 19/151). Almost all E18 isolates were detected in 2015, with the exception of one case which was detected in 2014. E18 was the predominant EV serotype, accounting for 74.4% (61/82) of all typed EVs isolated from patients with VE/VM in 2015 (Table [2](#ped412037-tbl-0002){ref-type="table"}).

###### 

Enterovirus serotypes identified in this study

            2013   2014   2015   Total N(%)             
  --------- ------ ------ ------ ------------ ---- ---- -----------
  CV‐A9     0      0      0      0            1    0    1 (0.7)
  CV‐B5     1      1      3      2            1    0    8 (5.3)
  E6        3      0      10     3            2    1    19 (12.6)
  E14       0      0      0      0            1    0    1 (0.7)
  E18       0      0      0      1            39   22   62 (41.1)
  E30       2      1      6      3            7    7    26 (17.2)
  E33       0      0      5      1            0    1    7 (4.6)
  Untyped   1      1      12     6            3    4    27
  Typed     8      34     82     124                    
  Total     10     52     89     151                    

John Wiley & Sons, Ltd

Prognosis of the patients {#ped412037-sec-0018}
-------------------------

Outcome data were available for all but one patient with VE who was transferred to another hospital. About 97.7% (301/308) of patients with VE recovered completely, while six patients developed neurological sequelae and one patient died. Neurological sequelae included epilepsy, coma, ataxia and visual impairment (Table [3](#ped412037-tbl-0003){ref-type="table"}). The patient who died was diagnosed with viral encephalitis caused by HSV1. All patients with VM recovered with no obvious neurologic sequelae.

###### 

Details of VE patients who developed neurological sequelae or died

  number   diseases       Age (years)   pathogens   hospitalization days (d)   Neurological sequelae
  -------- -------------- ------------- ----------- -------------------------- -----------------------
  1        encephalitis   1.0           E6          27                         Ataxia
  2        encephalitis   5.4           HHV6        10                         Coma
  3        encephalitis   1.0           HHV6        28                         Epilepsy
  4        encephalitis   4.5           unknown     20                         Ataxia
  5        encephalitis   6.0           unknown     25                         Visual impairment
  6        encephalitis   1.0           unknown     27                         Epilepsy
  7        encephalitis   2.2           HSV1        2                          Death

John Wiley & Sons, Ltd

DISCUSSION {#ped412037-sec-0019}
==========

The etiology of VE shows geographical variation.[9](#ped412037-bib-0009){ref-type="ref"} EVs have been reported as the leading causes of VE in China.[10](#ped412037-bib-0010){ref-type="ref"}, [11](#ped412037-bib-0011){ref-type="ref"} HSV was the most common causative agent of VE in the United States, England, France, Spain and eastern India,[12](#ped412037-bib-0012){ref-type="ref"}, [13](#ped412037-bib-0013){ref-type="ref"}, [14](#ped412037-bib-0014){ref-type="ref"}, [15](#ped412037-bib-0015){ref-type="ref"}, [16](#ped412037-bib-0016){ref-type="ref"} while JEV was reported as the primary viral pathogen responsible for VE among children in southern Vietnam and Thailand.[5](#ped412037-bib-0005){ref-type="ref"}, [17](#ped412037-bib-0017){ref-type="ref"} Infection by EVs was the leading cause of VM in many parts of the world.[16](#ped412037-bib-0016){ref-type="ref"}, [18](#ped412037-bib-0018){ref-type="ref"}, [19](#ped412037-bib-0019){ref-type="ref"}, [20](#ped412037-bib-0020){ref-type="ref"} Outbreaks of VM and VE associated with EV infection are usually caused by EV‐B, most commonly by serotypes CV‐B5, E6, and E30.[21](#ped412037-bib-0021){ref-type="ref"}, [22](#ped412037-bib-0022){ref-type="ref"}

VE and VM surveillance data based on human specimens is very limited in China. In this study, we studied the etiology of VE and VM among children in Hebei province, China. During the study period, the most common causative pathogens of VE and VM were EVs, followed by HSV1 and VZV, which is consistent with results of previous studies conducted in China.[11](#ped412037-bib-0011){ref-type="ref"}, [23](#ped412037-bib-0023){ref-type="ref"} EVs accounted for 55.7% (98/176) and 64.6% (53/82) of all cases of VE and VM with confirmed viral etiology, respectively. All EV serotypes belonged to the EV‐B group, including E6, E14, E18, E30, E33, CV‐A9 and CV‐B5. No EVs of either the EV‐A or EV‐C group were detected.

The most common serotypes of EV causing VE and VM showed temporal variations. E30 was reported to be the predominant serotype responsible for EV‐associated encephalitis in eastern China from 2002--2004 and 2010--2012, accounting for about 47.5% of VE cases from 2002 to 2012. E6 accounted for 32.0% of VE cases in eastern China in 2010.[24](#ped412037-bib-0024){ref-type="ref"} An aseptic meningitis outbreak caused by EV serotype E6 was also reported.[25](#ped412037-bib-0025){ref-type="ref"} In this study, the major EV serotypes observed were E6 and E30, which were detected in 25.0% and 17.3% of cases in 2014, respectively. E18, which was detected at low prevalence in mainland China in previous studies,[21](#ped412037-bib-0021){ref-type="ref"}, [23](#ped412037-bib-0023){ref-type="ref"} became the predominant EV serotype causing VE and VM in Hebei province in 2015.[6](#ped412037-bib-0006){ref-type="ref"} The E18 serotype of EV‐B has caused many outbreaks of aseptic meningitis in the USA,[26](#ped412037-bib-0026){ref-type="ref"}, [27](#ped412037-bib-0027){ref-type="ref"} Japan,[28](#ped412037-bib-0028){ref-type="ref"} Germany,[29](#ped412037-bib-0029){ref-type="ref"} and other regions.[30](#ped412037-bib-0030){ref-type="ref"}, [31](#ped412037-bib-0031){ref-type="ref"} Prior to our study, E18 had been detected sporadically and was rarely reported in mainland China.[23](#ped412037-bib-0023){ref-type="ref"} E18 has an epidemic pattern of circulation with increased levels of activity after prolonged quiescence. From 1970 to 2005 in the USA, two periods of increased E18 activity were observed (1986--1987 and 1995--2005). E18 activity reached its highest level in 2001. E18 appeared among the 15 most common enteroviruses in 18 of 36 years, from 1986 to 2005.[32](#ped412037-bib-0032){ref-type="ref"}

Knowledge of E18 molecular epidemiology has been very limited.[6](#ped412037-bib-0006){ref-type="ref"} High rates of nucleotide substitution and recombination are important mechanisms by which genetic diversity is propagated among EVs.[33](#ped412037-bib-0033){ref-type="ref"} Little data regarding molecular evolution of the virus was gained during a single outbreak. Further study is urgently needed to gain better insights into the prevalence of E18 infection in mainland China.

JEV is the main causative agent of serious VE worldwide; China, in particular, has a long history of high JEV prevalence.[34](#ped412037-bib-0034){ref-type="ref"} Since the JEV vaccine became available, the morbidity of JEV infection has declined sharply. It was also reported that JEV is much more prevalent in southern China as compared with northern China.[35](#ped412037-bib-0035){ref-type="ref"} All cases in this study were from northern China, which is consistent with the absence of JEV in this study population. EVs were the main causative agents responsible for VE and VM in children of Hebei province from Nov 2013 to Dec 2015. The majority of the EVs detected from the cases were from the EV‐B group, such as E18, E30, and E6. However, in this study, these viral investigations were confined to a relatively short time and to a limited area, limiting trend analyses of VE and VM pathogens. The surveillance data reflects only part of the reality of VE and VM prevalence in China. Further study is needed to understand the true situation. Ongoing national monitoring of the clinical and molecular epidemiology of EVs causing VE and VM is a key imperative.
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